Kawasaki Motorcycles Recall Issued Due to Faulty Ignition Switch

About 4,000 Kawasaki off-road motorcycles have been recalled due to a faulty ignition switch, which federal regulators say could cause the vehicle to starts suddenly and lead to a serious injury or death for riders. 

The U.S. Consumer Product Safety Commission (CPSC) announced the Kawasaki KLX110 off-road motorcycle recall on Thursday after problems with the housing on the ignition switch were discovered. The housing could allow water to enter the ignition switch and unexpectedly activate the bike’s electric starter.

Although there have been no reported injuries associated with the Kawasaki motorcycles, the CPSC warned that the defect “poses a serious hazard of injury or death.”

Did You Know?

Change Healthcare Data Breach Impacts Millions of Customers

A massive Change Healthcare data breach exposed the names, social security numbers, medical and personal information of potentially 100 million Americans, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The recall affects about 4,000 of the 2010 model year Kawasaki KLX110CAF and KLX110DAF off-road motorcycles. The models were sold in green and have Kawasaki printed on the fuel tank. The recalled motorcycles were sold at Kawasaki dealers nationwide from August 2009 through February 20 for about $2,100 each. The bikes were manufactured in Thailand.

The CPSC recommends that any consumers who own a recalled Kawasaki KLX110 off-road motorcycle stop using it immediately and contact a local Kawasaki Motorcycle dealer to make an appointment for a free repair. The company has attempted to alert all known KLX110 owners affected by the recall. Kawasaki owners with questions can visit the company’s website at www.kawasaki.com.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S.
Depo-Provera Brain Tumor Warnings Added to Drug Label in Europe, But Not In U.S. (Posted 2 days ago)

A recently filed Depo-Provera lawsuit questions why Pfizer updated the drug label in Europe, to warn about the risk of meningioma brain tumors, but failed to provide the same Depo-Provera warnings to U.S. consumers and doctors.

Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week
Hair Relaxer Lawsuit Status Conference To Be Held With MDL Judge This Week (Posted 4 days ago)

U.S. District Judge presiding over all federal hair relaxer lawsuits will meet with lawyers involved in the litigation on Thursday, to discuss the status of the claims and when to move forward with bellwether cases.